Sanofi’s $700M Investment in Genetic Diseases

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Jan. 30 (Bloomberg) –- Alnylam Pharmaceuticals President & COO Barry Greene and Bloomberg’s Meg Tirrell discuss a new technology that shuts down production of proteins that cause disease with Pimm Fox on Bloomberg Televisions “Taking Stock.” (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change